IBSA is glad to reconfirm its presence at the Annual Congress of The European League Against Rheumatism, that is one of the most relevant congresses in the world of rheumatology. IBSA will participate with a Satellite Symposium which will focus on our highly purified, pharmaceutical-grade chondroitin sulfate, with new evidences that have recently become available. See the full programme here.
All people interested in knowing more about IBSA as leading company in the field of OA and Pain, and about its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous and bolus i.v. diclofenac) are also invited to visit us in the exhibition hall (stand #340B).